Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
300 IR grass pollen allergen extract tablet
DRUG
3 trials
Sponsors
Stallergenes Greer
Conditions
Allergy
Seasonal Allergic Rhinitis
Phase 1
Efficacy and Safety of Sublingual Tablets of Grass Pollen Allergen Extract
Completed
NCT00619827
Stallergenes Greer
Seasonal Allergic Rhinitis
Start: 2007-09-30
End: 2008-03-31
Updated: 2016-05-23
Phase 2
Safety and Efficacy of Sublingual Immunotherapy (SLIT) Tablets in Grass Pollen Rhinoconjunctivitis
Completed
NCT00367640
Stallergenes Greer
Allergy
Start: 2004-11-30
End: 2005-09-30
Updated: 2016-05-23
Phase 3
Efficacy and Safety of 300 IR Sublingual Immunotherapy (SLIT) Tablets in Children Suffering From Grass Pollen Rhinoconjunctivitis
Completed
NCT00409409
Stallergenes Greer
Allergy
Start: 2006-12-31
End: 2007-09-30
Updated: 2016-05-26
Related Papers
Comparison of scores associating symptoms and rescue medication use for evaluating the efficacy of allergy immunotherapy in seasonal allergic rhinoconjunctivitis: results from five trials.
2016-12-02
5 citations
Heterogeneity of antibody responses among clinical responders during grass pollen sublingual immunotherapy.
2013-12-01
23 citations
Allergen-specific CD4+ T cell responses in peripheral blood do not predict the early onset of clinical efficacy during grass pollen sublingual immunotherapy.
2012-12-01
37 citations